Direct-acting skeletal muscle relaxant
Indirect-acting cholinergic agonist
Narcotic agonist-antagonist
Anticholinergic agent
Dopaminergic agent
Narcotic Agonist
Centrally-acting skeletal muscle relaxant
Narcotic antagonist
Direct-acting cholinergic agonist
_____Prototype: Pentazocine (Talwin)_____Indications: relief of moderate to severe pain; preanesthetic medication & supplement to surgical anesthesia.
_____Prototype: Naloxone (Narcan)_____Indications: reversal agent for opioid overdose; complete or partial reversal of narcotic depression.
_____Prototype: Bethanechol (Duvoid)_____Indications: non-obstructive urinary retention (postoperative, postpartum, or neurogenic bladder)
_____Prototype: Baclofen (Lioresal)_____Indications: Alleviation of s/s of spasticity, for use in spinal cord injuries or spinal cord diseases.
_____Prototype: Pyridostigmine (Mestinon)_____Indications: Treatment of myesthenia gravis; antidote for nondepolarizing neuromuscular junction blockers; nerve gas antidote.
_____Prototype: Dantrolene (Dantrium)_____Indications: Control of spasticity resulting from UMN disorders; Preoperatively to prevent/manage malignant hyperthermia
_____Prototype: Morphine (Rexanol)_____Indications: Relief of moderate to severe acute or chronic pain.
_____Prototype: Benztropine (Cogentin)_____Indications: Adjunctive therapy for Parkinson's disease; relief of symptoms of parkinsonism that accompany neuroleptic therapy.
_____Prototype: Levadopa (generic)_____Indications: Treatment of parkinsonism and Parkinson's disease.
